Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Look it up: How well did your school do on the spring 2024 state tests?
Recommended
Check your car registration: 5 On Your Side finds hundreds of drivers paying wrong fees
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by GENENTA SCIENCE SPA
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
May 06, 2024
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Tickers
ARYD
GNTA
SQZ
Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors
February 08, 2024
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Tickers
GNTA
Genenta to Present at Upcoming Scientific and Investor Conferences
September 06, 2023
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Tickers
GNTA
Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments
July 28, 2023
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Tickers
GNTA
The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma
June 29, 2023
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Tickers
GNTA
Genenta to Provide Update on Lead Product Temferon™
May 16, 2023
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Tickers
GNTA
Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing
April 26, 2023
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Tickers
GNTA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.